Salvage therapies after failure of <i>Helicobacter pylori</i> eradication with ranitidine bismuth citrate‐based therapies

Abstract

One-week OAC is not an optimal second-line therapy when RBC-clarithromycin combinations fail. Quadruple therapy appears to be effective despite repeated failures of clarithromycin-based RBC or proton pump inhibitor therapies.